• Explore /
  • Poster
  • / Phase Ib trial of varlitinib plus weekly paclitaxel in EGFR/HER2 co-expressing advanced gastric cancer (AGC).

Phase Ib trial of varlitinib plus weekly paclitaxel in EGFR/HER2 co-expressing advanced gastric cancer (AGC).

Abstract Poster

Authors

null

Yunbeom Sang

Division of Medical Oncology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, South Korea

Yunbeom Sang , Minkyu Jung , Hyo Song Kim , Beodeul Kang , Choong-kun Lee , Hyun Cheol Chung , Sun Young Rha

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2021 Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session: Esophageal and Gastric Cancer

Track

Esophageal and Gastric Cancer

Sub Track

Therapeutics

Clinical Trial Registration Number

KCT0003583

Citation

J Clin Oncol 39, 2021 (suppl 3; abstr 227)

DOI

10.1200/JCO.2021.39.3_suppl.227

Abstract #

227

Poster Bd #

Online Only

Abstract Disclosures

Similar Posters

First Author: Milind M. Javle

First Author: Milind M. Javle

First Author: Dan Liu

First Author: Timothy Jay Price